Effects of rTMS and tDCS in balance of MS patients
Not Applicable
- Conditions
- Multiple Sclerosis (MS).
- Registration Number
- IRCT20210905052374N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Clinically definite MS
Age > 20 and <65 years
Disability between 4.5 and 6.5 on the Expanded Disability Status Scale (EDSS)
Walking ability according to the EDSS score
A minimal leg spasticity score = 1 on the Modified Ashworth spasticity scale
Exclusion Criteria
Pregnant women
Neurological, orthopedic and severe cardiac comorbidities
Peripheral vestibular disorders (i.e., positional paroxysmal vertigo, Meniere’s disease, and acoustic neuroma)
Blindness in one or both eyes
Exacerbation in the past 2 months
Exacerbation during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The stability indices at both static and dynamic levels of the Biodex Balance System. Timepoint: Before and after the intervention. Method of measurement: The Biodex Balance System (302-950 model, Biodex Medical Systems, Inc., New York, USA).
- Secondary Outcome Measures
Name Time Method The Berg Balance Scale Score. Timepoint: Before and after the intervention. Method of measurement: Questionnaire.